Kelly Financial Services LLC Aldeyra Therapeutics, Inc. Transaction History

Kelly Financial Services LLC

  • $258 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 17, 2024
SELL
$2.43 - $4.85 $6,092 - $12,158
-2,507 Closed
0 $0
Q3 2021

Jul 17, 2024
SELL
$7.94 - $11.31 $205,622 - $292,895
-25,897 Reduced 91.17%
2,507 $22 Million
Q2 2021

Jul 17, 2024
BUY
$10.44 - $14.85 $270,364 - $384,570
25,897 Added 1032.99%
28,404 $2.51 Million
Q3 2020

Jul 17, 2024
BUY
$4.0 - $7.53 $10,028 - $18,877
2,507 New
2,507 $18.6 Million

Others Institutions Holding ALDX

# of Institutions
107
Shares Held
35.2M
Call Options Held
153K
Put Options Held
83.9K
View Full List

About Aldeyra Therapeutics, Inc.

ALDX Quotes by TradingView
  • Ticker ALDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,323,100
  • Market Cap $322M
  • Description
  • Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...
More about ALDX
Track This Portfolio

Track Kelly Financial Services LLC Portfolio

Follow Kelly Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kelly Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kelly Financial Services LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email